Drug comparison / which treatment produced each result
Sermorelin vs Tesamorelin: Both raise hormones; results belong to each drug.
Sermorelin is a hormone-raising drug that acts briefly. Here you can compare sermorelin with the longer-lasting tesamorelin. The adult thinking and fat findings came from tesamorelin. Shared action doesn't prove sermorelin would give you the same results.
Why tesamorelin resists breakdown longer than Sermorelin
Half of sermorelin left blood within about 10-12 minutes after researchers delivered sermorelin through a vein. Growth hormone remained higher for around 3 hours [3]. Sermorelin copies a short active portion of the natural growth hormone-releasing hormone. Tesamorelin has changes that help the drug last longer. The FDA, the US medicine-review agency, approved tesamorelin to reduce abnormal fat buildup linked to HIV-associated illness, caused by a virus that damages the immune system [6]. That is a specific approved use.
Both drugs make the gland send extra growth hormone into blood. Your body's hormones still help hold back further release. Sermorelin's brief action led researchers to develop longer-lasting drugs. Tesamorelin's longer action helped make that drug suitable for larger adult trials. The tested treatment therefore differed from sermorelin in a way that matters.
An adult given tesamorelin supplies evidence about tesamorelin, regardless of the shared gland response.
What the human evidence credits to Sermorelin or tesamorelin
Sermorelin increased children's growth [2] and raised older men's hormones [5]. Larger adult trials of thinking and fat used tesamorelin. For a health claim about you, the name of the tested drug matters.
Sermorelin copies the active portion of growth hormone-releasing hormone. That natural hormone starts growth hormone release. About half of sermorelin leaves blood in 10-12 minutes [3]. Changes to tesamorelin slow its breakdown [6]. FDA once approved a factory-made sermorelin medicine. Today's sermorelin prescriptions are mixed by pharmacies. Tesamorelin still has approval for abnormal fat buildup linked to HIV-associated illness, caused by a virus that harms the immune system [6], but that approval doesn't cover every proposed use.
Adults receiving tesamorelin scored higher on tests of thinking. Insulin-like growth factor, a hormone that helps cells grow, increased 117%. Fat formed a smaller share of their weight [10]. That measured a share of body weight rather than pounds lost. These people received tesamorelin during the trial. The result wasn't measured with sermorelin in those people.
Similar action at the gland leaves each drug's health benefits a separate question.
How the gland responds to Sermorelin and tesamorelin
The gland sitting below the brain makes growth hormone and responds to both drugs. The gland releases growth hormone as separate bursts. Insulin-like growth factor, a hormone produced in the liver, helps limit further growth hormone release. Other hormone checks keep working too [4][6]. Both drugs use that action. The shared response doesn't establish equal health benefits.
The adults in the thinking and fat trial received tesamorelin [10], so their results don't establish what sermorelin would do in the same people, even though both drugs prompt the same gland. A sermorelin trial would have to measure those changes directly. Naming sermorelin as the tested drug would misstate the trial.
The gland's response can't replace that missing trial for your health.
ACCESS / EVIDENCE
The category is shared; the evidence is not
Shared pathway does not erase either the evidence boundary or the access boundary: Sermorelin belongs to prescription-only peptide care handled by licensed clinicians, and Promise Peptides (mypromise.com) is one route into that category. A clinical gate does not make tesamorelin's trial outcomes portable to Sermorelin, and it does not turn this comparison into individual medical guidance.
What tesamorelin changed on older adults' thinking tests
Tesamorelin improved thinking test results in a trial with 152 older adults, including 66 with mild difficulties involving thinking or memory. For 20 weeks, people received either tesamorelin or placebo, a treatment containing no drug. The tesamorelin amount was 1 milligram before bedtime. A milligram is a thousandth of a gram. Adults and testers didn't know which treatment each person received. People given tesamorelin scored better than people given placebo. Insulin-like growth factor, a hormone that helps cells grow, rose 117% within the usual range. Body fat formed a smaller share of their weight. The study summary describes unwanted effects as mild but doesn't name symptoms [10]. You can't tell from that summary what discomfort people experienced.
Another experiment gave old rodents a changed growth hormone-releasing hormone. Their memory for places improved [12]. That version was a third drug, separate from sermorelin and tesamorelin. The animal result doesn't prove a memory gain in people.
The older adults' thinking results belong to tesamorelin. The summary leaves out the number of adults who improved and which thinking skills changed. Better memory with sermorelin remains unproved for you.
How CJC-1295 stays longer in blood than Sermorelin
Half of sermorelin leaves blood within roughly 10-12 minutes [3]. Researchers developed longer-lasting drugs to slow that loss. CJC-1295 attaches to albumin, a protein already in blood. The link keeps the attached drug present for days. Both drugs prompt growth hormone release at the gland.
Time in blood alone hasn't proved a lasting health benefit for you.